Plain-English translation of NCT07301489 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding heart disease screening to routine lung cancer screening can help find heart problems before they cause a heart attack in people who have smoked heavily. Researchers will use CT scans that are already being done for lung cancer screening to look for signs of heart disease. The goal is to catch dangerous heart conditions early, when they can still be treated.
Heart disease is the leading cause of death in smokers, and many people don't realize they have it until they have a sudden heart attack. This study exists to see if screening smokers for heart disease during lung cancer screening visits can find these hidden problems before they become life-threatening.
You likely qualify if…
You likely don't qualify if…
You will be part of the lung cancer screening program and will receive additional heart disease screening. Some participants will receive follow-up care coordinated by nurses at the hospital, while others will have follow-up managed by their regular doctor. You will need to attend visits and complete heart health evaluations, with a follow-up visit about 1 year after your initial screening. The study will continue to monitor your health for at least 5 years.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Norway